CRMD - CorMedix Inc.

QQQ $ 608.59 $ -9.26 (-1.5 %)

DIA $ 475.50 $ -6.59 (-1.37 %)

SPY $ 672.57 $ -8.41 (-1.24 %)

TLT $ 89.38 $ -0.42 (-0.46 %)

GLD $ 384.40 $ -4.31 (-1.11 %)

Previous Close

$ 11.21

Open

$ 11.47

Bid

$ 11.11 x 200

Ask

$ 11.40 x 3,939

Day's Range

-- - --

52 Week Range

$ 5.60 - $ 17.43

Volume

5,982,080

Average Volume

Market Cap

966.46M

Beta (5Y Monthly)

$ 1.72

PE Ratio (TTM)

$ 5.95

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-12-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	03-25-2025	12-31-2024	10-K
5	10-30-2024	09-30-2024	10-Q
6	08-14-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	03-12-2024	12-31-2023	10-K
9	11-14-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-15-2023	03-31-2023	10-Q
12	03-30-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-29-2022	12-31-2021	10-K
17	11-09-2021	09-30-2021	10-Q
18	08-12-2021	06-30-2021	10-Q
19	05-13-2021	03-31-2021	10-Q
20	03-30-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-10-2020	06-30-2020	10-Q
23	05-11-2020	03-31-2020	10-Q
24	03-16-2020	12-31-2019	10-K
25	11-14-2019	09-30-2019	10-Q
26	08-14-2019	06-30-2019	10-Q
27	05-13-2019	03-31-2019	10-Q
28	03-14-2019	12-31-2018	10-K
29	11-14-2018	09-30-2018	10-Q
30	08-14-2018	06-30-2018	10-Q
31	05-15-2018	03-31-2018	10-Q
32	03-19-2018	12-31-2017	10-K
33	11-09-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-10-2017	03-31-2017	10-Q
36	03-16-2017	12-31-2016	10-K
37	11-09-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	05-10-2016	03-31-2016	10-Q
40	03-15-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Corme...
11/13/2025 12:29:46

HC Wainwright & Co. analyst Brandon Folkes maintains Cormedix (NASDAQ:CRMD) with a Buy and raises the price target from ...

D. Boral Capital Maintains Buy on Cormedix...
11/12/2025 19:09:45

D. Boral Capital analyst Jason Kolbert maintains Cormedix (NASDAQ:CRMD) with a Buy and maintains $14 price target.

Needham Maintains Buy on Cormedix, Lowers ...
11/12/2025 19:00:08

Needham analyst Serge Belanger maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from $20 to $16.

cormedix-q3-profit-soars-as-defencath-dialysis-demand-exceeds-expectations

CorMedix Q3 Profit Soars As DefenCath Dial...
11/12/2025 16:49:31

CorMedix posts strong Q3 results with $104 million in revenue, higher DefenCath sales, and raises 2025 guidance following Melin...

pharming-group-posts-upbeat-q3-results-joins-on-holding-bigbearai-holdings-and-other-big-stocks-moving-higher-on-wednesday

Pharming Group Posts Upbeat Q3 Results, Jo...
11/12/2025 16:19:01

UPDATE: Cormedix Q3 Adj. EPS $0.57 Misses ...
11/12/2025 13:55:13

Cormedix Sees FY2025 Sales $390.000M-$410....
11/12/2025 12:40:32

CorMedix again raises its full-year 2025 pro forma net revenue guidance to a range of $390 to $410 million, and fourth quarter ...

Cormedix Sees Q4 Sales $115.000M-$135.000M...
11/12/2025 12:40:18

Cormedix (NASDAQ:CRMD) sees Q4 sales of $115.000 million-$135.000 million vs $118.847 million analyst estimate.

Cormedix Q3 EPS $1.26 Beats $0.63 Estimate...
11/12/2025 12:32:10

Cormedix (NASDAQ:CRMD) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $0.63 by 100...

Earnings Scheduled For November 12, 2025
11/12/2025 11:11:28

top-stocks-with-earnings-this-week-plug-oklo-circle-and-more

Top Stocks With Earnings This Week: Plug, ...
11/10/2025 13:38:37

Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, P...

CorMedix Says DefenCath Receives Innovativ...
10/23/2025 12:32:58

CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for lif...

Beyond The Numbers: 4 Analysts Discuss Cor...
10/21/2025 22:01:38

RBC Capital Maintains Outperform on Cormed...
10/21/2025 14:34:57

RBC Capital analyst Leonid Timashev maintains Cormedix (NASDAQ:CRMD) with a Outperform and raises the price target from $21 ...

D. Boral Capital Upgrades Cormedix to Buy,...
10/20/2025 13:33:06

D. Boral Capital analyst Jason Kolbert upgrades Cormedix (NASDAQ:CRMD) from Hold to Buy and announces $14 price target.

Market-Moving News for October 20th
10/20/2025 11:36:19

REPL: 81% | The FDA Accepts Replimune's Resubmission Of The Biologics License Application For RP1 In Combination With Nivol...

CorMedix Sees Q3 Unaudited Pro Forma Net R...
10/20/2025 11:32:37

CorMedix Files For Offering Of Up To 6.3M ...
09/30/2025 21:22:55

https://www.sec.gov/Archives/edgar/data/1410098/000121390025094067/ea0258874-s3_cormedix.htm

CorMedix Completes Enrollment In Phase III...
09/29/2025 13:20:34

- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allo...

Analyst Expectations For Cormedix's Future
09/09/2025 18:01:00